Swing Trade Stock Picks

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 12/17/2018 – 12/21/2018:

1) ACHV – Achieve Life Sciences, Inc. – Trading Below Cash
a. Buy at < ~ $1.32
b. Sell at >~ $5.20
c. Catalysts:
1. Phase 2 – Trial of Cytisine in Adult Smokers; 20190512; 20190630; https://ClinicalTrials.gov/show/NCT03709823

2) ARCW – ARC Group Worldwide, Inc.
a. Buy at < ~ $0.91
b. Sell at >~ $2.60

3) NNDM – Nano Dimension Ltd.
a. Buy at < ~ $1.21
b. Sell at >~ $3.35

4) LIFE – aTyr Pharma, Inc. – Trading Below Cash
a. Buy at < ~ $0.45
b. Sell at >~ $0.82
c. Catalysts:
1. In the fourth quarter of 2018, aTyr plans to initiate a Phase 1b/2a multiple-ascending dose, placebo-controlled, first-in-patient study with ATYR1923 …; 20181001; 20181231; https://finance.yahoo.com/news/atyr-pharma-announces-pulmonary-sarcoidosis-200500950.html

5) KOPN – Kopin Corporation
a. Buy at < ~ $1.37
b. Sell at >~ $1.95

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks < ~ $10 to Buy next week, 12/17/2018 – 12/21/2018, and Why?

Disclaimer

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 12/14/2018 include:

1. $ADXS – Advaxis, Inc. :
   1. Cash/sh = $0.54
2. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
3. $CFMS – Conformis, Inc. :
   1. Cash/sh = $0.55
4. $CHFS – CHF Solutions, Inc. :
   1. Cash/sh = $1.17
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $0.59
6. $CUR – Neuralstem, Inc. :
   1. Cash/sh = $0.45
7. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $1.53
8. $DCAR – DropCar, Inc. :
   1. Cash/sh = $0.35
9. $IPWR – Ideal Power Inc. :
   1. Cash/sh = $0.41
10. $MBOT – Microbot Medical Inc. :
    1. Cash/sh = $2.17
11. $OMED – OncoMed Pharmaceuticals, Inc. :
    1. Cash/sh = $1.75
12. $OXBR – Oxbridge Re Holdings Limited :
    1. Cash/sh = $1.32
13. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Cash/sh = $2.17
14. $TCON – TRACON Pharmaceuticals, Inc. :
    1. Cash/sh = $1.79
15. $TRVN – Trevena, Inc. :
    1. Cash/sh = $0.94
16. $VBLT – Vascular Biogenics Ltd. :
    1. Cash/sh = $1.71
17. $VXRT – Vaxart, Inc. :
    1. Cash/sh = $2.96

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

#TradingBelowCash #TBC #StockPicks #Stock #Market #Trading

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 12/14/2018 include:

1. $ADXS – Advaxis, Inc. :
   1. Book/sh = $0.63
2. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
3. $CFMS – Conformis, Inc. :
   1. Book/sh = $0.72
4. $CHFS – CHF Solutions, Inc. :
   1. Book/sh = $1.38
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $0.78
6. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $1.38
7. $DCAR – DropCar, Inc. :
   1. Book/sh = $1.15
8. $DTEA – DAVIDsTEA Inc. :
   1. Book/sh = $2.65
9. $GSAT – Globalstar, Inc. :
   1. Book/sh = $0.30
10. $HMNY – Helios and Matheson Analytics Inc. :
    1. Book/sh = $113.81
11. $IPWR – Ideal Power Inc. :
    1. Book/sh = $0.46
12. $JAGX – Jaguar Health, Inc. :
    1. Book/sh = $1.23
13. $KOOL – Cesca Therapeutics Inc. :
    1. Book/sh = $0.70
14. $MBOT – Microbot Medical Inc. :
    1. Book/sh = $2.23
15. $OMED – OncoMed Pharmaceuticals, Inc. :
    1. Book/sh = $1.34
16. $OSN – Ossen Innovation Co., Ltd. :
    1. Book/sh = $15.50
17. $OXBR – Oxbridge Re Holdings Limited :
    1. Book/sh = $2.57
18. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Book/sh = $1.32
19. $TCON – TRACON Pharmaceuticals, Inc. :
    1. Book/sh = $1.24
20. $TISA – Top Image Systems Ltd. :
    1. Book/sh = $0.78
21. $TRVN – Trevena, Inc. :
    1. Book/sh = $0.63
22. $VBLT – Vascular Biogenics Ltd. :
    1. Book/sh = $2.03
23. $VXRT – Vaxart, Inc. :
    1. Book/sh = $3.13
24. $XGTI – xG Technology, Inc. :
    1. Book/sh = $0.58

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

#StockPicks #Stock #Market #Trading

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 01/04/2019 include:

1. $ACHV – Achieve Life Sciences, Inc. :
   1. Cash/sh = $2.12
2. $ADXS – Advaxis, Inc. :
   1. Cash/sh = $0.53
3. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
4. $CFMS – Conformis, Inc. :
   1. Cash/sh = $0.55
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $0.59
6. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $1.53
7. $FCSC – Fibrocell Science, Inc. :
   1. Cash/sh = $1.74
8. $IPWR – Ideal Power Inc. :
   1. Cash/sh = $0.41
9. $MBOT – Microbot Medical Inc. :
   1. Cash/sh = $2.17
10. $OMED – OncoMed Pharmaceuticals, Inc. :
    1. Cash/sh = $1.75
11. $OXBR – Oxbridge Re Holdings Limited :
    1. Cash/sh = $1.32
12. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Cash/sh = $2.17
13. $TCON – TRACON Pharmaceuticals, Inc. :
    1. Cash/sh = $1.79
14. $TRVN – Trevena, Inc. :
    1. Cash/sh = $0.84
15. $VBLT – Vascular Biogenics Ltd. :
    1. Cash/sh = $2.11
16. $VXRT – Vaxart, Inc. :
    1. Cash/sh = $2.50
17. $XNET – Xunlei Limited :
    1. Cash/sh = $5.17

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

#TradingBelowCash #TBC #StockPicks #Stock #Market #Trading

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 01/04/2019 include:

1. $ACHV – Achieve Life Sciences, Inc. :
   1. Book/sh = $3.12
2. $ADXS – Advaxis, Inc. :
   1. Book/sh = $0.63
3. $ARCW – ARC Group Worldwide, Inc. :
   1. Book/sh = $1.31
4. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
5. $CFMS – Conformis, Inc. :
   1. Book/sh = $0.72
6. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $0.78
7. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $1.38
8. $DCAR – DropCar, Inc. :
   1. Book/sh = $0.88
9. $DTEA – DAVIDsTEA Inc. :
   1. Book/sh = $2.32
10. $GROW – U.S. Global Investors, Inc. :
    1. Book/sh = $1.61
11. $HMNY – Helios and Matheson Analytics Inc. :
    1. Book/sh = $0.15
12. $IPWR – Ideal Power Inc. :
    1. Book/sh = $0.46
13. $JAGX – Jaguar Health, Inc. :
    1. Book/sh = $1.23
14. $KOOL – Cesca Therapeutics Inc. :
    1. Book/sh = $0.70
15. $MBOT – Microbot Medical Inc. :
    1. Book/sh = $2.23
16. $NNDM – Nano Dimension Ltd. :
    1. Book/sh = $1.44
17. $OMED – OncoMed Pharmaceuticals, Inc. :
    1. Book/sh = $1.34
18. $OSN – Ossen Innovation Co., Ltd. :
    1. Book/sh = $15.50
19. $OXBR – Oxbridge Re Holdings Limited :
    1. Book/sh = $2.57
20. $PHIO – Phio Pharmaceuticals :
    1. Book/sh = $0.80
21. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Book/sh = $1.32
22. $TCON – TRACON Pharmaceuticals, Inc. :
    1. Book/sh = $1.24
23. $TISA – Top Image Systems Ltd. :
    1. Book/sh = $0.63
24. $TRVN – Trevena, Inc. :
    1. Book/sh = $0.63
25. $VBLT – Vascular Biogenics Ltd. :
    1. Book/sh = $2.03
26. $VXRT – Vaxart, Inc. :
    1. Book/sh = $2.24
27. $XGTI – xG Technology, Inc. :
    1. Book/sh = $0.58
28. $XNET – Xunlei Limited :
    1. Book/sh = $5.57

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

#StockPicks #Stock #Market #Trading

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 02/01/2019 include:

1. $ADXS – Advaxis, Inc. :
   1. Cash/sh = $0.74
2. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
3. $CHFS – CHF Solutions, Inc. :
   1. Cash/sh = $16.40
4. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $0.68
5. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $1.54
6. $IPWR – Ideal Power Inc. :
   1. Cash/sh = $0.39
7. $OMED – OncoMed Pharmaceuticals, Inc. :
   1. Cash/sh = $1.86
8. $RTTR – Ritter Pharmaceuticals, Inc. :
   1. Cash/sh = $2.14
9. $TCON – TRACON Pharmaceuticals, Inc. :
   1. Cash/sh = $1.79
10. $VBLT – Vascular Biogenics Ltd. :
    1. Cash/sh = $1.74
11. $VXRT – Vaxart, Inc. :
    1. Cash/sh = $2.33
12. $XNET – Xunlei Limited :
    1. Cash/sh = $5.14

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

#TradingBelowCash #TBC #StockPicks #Stock #Market #Trading

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 02/01/2019 include:

1. $ADXS – Advaxis, Inc. :
   1. Book/sh = $0.39
2. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
3. $CFMS – Conformis, Inc. :
   1. Book/sh = $0.72
4. $CHFS – CHF Solutions, Inc. :
   1. Book/sh = $19.34
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $0.78
6. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $1.38
7. $DCAR – DropCar, Inc. :
   1. Book/sh = $0.88
8. $DTEA – DAVIDsTEA Inc. :
   1. Book/sh = $2.33
9. $GROW – U.S. Global Investors, Inc. :
   1. Book/sh = $1.61
10. $HMNY – Helios and Matheson Analytics Inc. :
    1. Book/sh = $0.15
11. $IPWR – Ideal Power Inc. :
    1. Book/sh = $0.46
12. $JAGX – Jaguar Health, Inc. :
    1. Book/sh = $0.86
13. $KOOL – Cesca Therapeutics Inc. :
    1. Book/sh = $0.70
14. $MLND – Millendo Therapeutics, Inc. :
    1. Book/sh = $18.82
15. $NNDM – Nano Dimension Ltd. :
    1. Book/sh = $1.44
16. $OMED – OncoMed Pharmaceuticals, Inc. :
    1. Book/sh = $1.34
17. $OSN – Ossen Innovation Co., Ltd. :
    1. Book/sh = $15.96
18. $PHIO – Phio Pharmaceuticals :
    1. Book/sh = $0.80
19. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Book/sh = $1.32
20. $TCON – TRACON Pharmaceuticals, Inc. :
    1. Book/sh = $1.24
21. $TISA – Top Image Systems Ltd. :
    1. Book/sh = $0.63
22. $UAVS – AgEagle Aerial Systems, Inc. :
    1. Book/sh = $0.48
23. $VBLT – Vascular Biogenics Ltd. :
    1. Book/sh = $2.03
24. $VXRT – Vaxart, Inc. :
    1. Book/sh = $2.24
25. $XGTI – xG Technology, Inc. :
    1. Book/sh = $0.58
26. $XNET – Xunlei Limited :
    1. Book/sh = $5.57

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

#StockPicks #Stock #Market #Trading

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 03/10/2019 include:

1. $ADXS – Advaxis, Inc. :
   1. Cash/sh = $0.59
2. $AKAO – Achaogen, Inc. :
   1. Cash/sh = $0.86
3. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
4. $CHFS – CHF Solutions, Inc. :
   1. Cash/sh = $13.44
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $10.41
6. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $1.50
7. $OMED – OncoMed Pharmaceuticals, Inc. :
   1. Cash/sh = $1.92
8. $RTTR – Ritter Pharmaceuticals, Inc. :
   1. Cash/sh = $2.13
9. $TCON – TRACON Pharmaceuticals, Inc. :
   1. Cash/sh = $1.79

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

#TradingBelowCash #TBC #StockPicks #Stock #Market #Trading

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 03/10/2019 include:

1. $ADXS – Advaxis, Inc. :
   1. Book/sh = $0.39
2. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
3. $CHFS – CHF Solutions, Inc. :
   1. Book/sh = $19.34
4. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $11.74
5. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $1.38
6. $DCAR – DropCar, Inc. :
   1. Book/sh = $0.88
7. $DTEA – DAVIDsTEA Inc. :
   1. Book/sh = $2.33
8. $GROW – U.S. Global Investors, Inc. :
   1. Book/sh = $1.61
9. $HMNY – Helios and Matheson Analytics Inc. :
   1. Book/sh = $0.15
10. $IPWR – Ideal Power Inc. :
    1. Book/sh = $0.46
11. $JAGX – Jaguar Health, Inc. :
    1. Book/sh = $0.86
12. $KOOL – Cesca Therapeutics Inc. :
    1. Book/sh = $0.70
13. $MLND – Millendo Therapeutics, Inc. :
    1. Book/sh = $18.82
14. $NNDM – Nano Dimension Ltd. :
    1. Book/sh = $1.44
15. $OMED – OncoMed Pharmaceuticals, Inc. :
    1. Book/sh = $1.34
16. $OSN – Ossen Innovation Co., Ltd. :
    1. Book/sh = $15.96
17. $PHIO – Phio Pharmaceuticals :
    1. Book/sh = $0.80
18. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Book/sh = $1.32
19. $VISL – Vislink Technologies, Inc. :
    1. Book/sh = $0.58

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

#StockPicks #Stock #Market #Trading

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 08/05/2018 – 08/09/2019:

1) MARK – Remark Holdings, Inc.
a. Buy at <~ $0.81
b. Sell at >~ $3.35

2) CGIX – Cancer Genetics, Inc.
a. Buy at <~ $0.13
b. Sell at >~ $0.34
c. Catalysts:
1. Phase 1Phase 2 – Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer; 20200220; 20200920; https://ClinicalTrials.gov/show/NCT02842125
2. – The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.; 20200301; 20210101; https://ClinicalTrials.gov/show/NCT03857477
3. NA – Testing a Culturally Adapted Telephone Genetic Counseling Intervention; 20200331; 20200331; https://ClinicalTrials.gov/show/NCT03959267
4. Phase 2 – Safety and Efficacy of Ad-p53 in Head and Neck Cancer; 20200101; 20200901; https://ClinicalTrials.gov/show/NCT03544723
5. – The IMPACT Study – Identification of Men With a Genetic Predisposition to ProstAte Cancer; 20191201; 20211231; https://ClinicalTrials.gov/show/NCT00261456
6. – Estrogen, Diet, Genetics and Endometrial Cancer; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT00587886
7. – Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT03648151
8. – Genetic Testing for Men With Metastatic Prostate Cancer; 20200821; 20200821; https://ClinicalTrials.gov/show/NCT03503097
9. NA – Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer; 20200901; 20260930; https://ClinicalTrials.gov/show/NCT02823652
10. NA – Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen); 20201130; 20231130; https://ClinicalTrials.gov/show/NCT03328091
11. – A Prognosis and Predicting Genetic Study of Lung Cancer; 20200801; 20370801; https://ClinicalTrials.gov/show/NCT03234179
12. NA – Cancer Health Assessments Reaching Many; 20200531; 20210531; https://ClinicalTrials.gov/show/NCT03426878
13. NA – Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins; 20200701; 20220731; https://ClinicalTrials.gov/show/NCT02965755
14. – Interest and Impact of Skin Cancer Genetic Testing; 20200801; 20200831; https://ClinicalTrials.gov/show/NCT02941900
15. – Genetics of Wilms Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies; 20191201; 20201231; https://ClinicalTrials.gov/show/NCT00503893
16. – The BARCODE 1 Study; 20181231; 20210429; https://ClinicalTrials.gov/show/NCT03158922
17. – Genetic Susceptibility to Bladder Cancer; 20190801; 20190831; https://ClinicalTrials.gov/show/NCT00848289
18. – Interest and Impact of Skin Cancer Genetic Testing; 20190801; 20190831; https://ClinicalTrials.gov/show/NCT02941900
19. – The BARCODE 1 Study; 20181231; 20210429; https://ClinicalTrials.gov/show/NCT03158922
20. NA – Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor – NGSKids; 20141117; 20201231; https://ClinicalTrials.gov/show/NCT02546453
21. – Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland; 20180331; 20220930; https://ClinicalTrials.gov/show/NCT03124212
22. – The BARCODE 1 Study; 20180414; 20210429; https://ClinicalTrials.gov/show/NCT03158922
23. – Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT02542670
24. – Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT03934606
25. – Exploring the Link Between Cancer Genetics and PPSP; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT04007861
26. – Early Onset and Familial Gastric Cancer Registry; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT00582257
27. – Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes; 20190901; 20190930; https://ClinicalTrials.gov/show/NCT02917798
28. – DNA Repair and Genetic Susceptibility to Lung Cancer; 20190901; 20190930; https://ClinicalTrials.gov/show/NCT00611598
29. – Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT00579163

3) SGLB – Sigma Labs, Inc.
a. Buy at <~ $0.70
b. Sell at >~ $1.50

4) PRTO – Proteon Therapeutics, Inc. – Trading Below Cash
a. Buy at <~ $0.35
b. Sell at >~ $0.65
c. Catalysts:
1. Phase 1 – Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK); 20190601; 20200131; https://ClinicalTrials.gov/show/NCT02956993
2. Phase 1 – Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT02953496
3. Phase 3 – A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2); 20210201; 20210228; https://ClinicalTrials.gov/show/NCT02414841

5) INUV – Inuvo, Inc.
a. Buy at <~ $0.26
b. Sell at >~ $0.44

6) ATNM – Actinium Pharmaceuticals, Inc.
a. Buy at <~ $0.23
b. Sell at >~ $0.38
c. Catalysts:
1. Phase 3 – Study of Iomab-B Prior to Hematopoietic Cell Transplant vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia; 20191201; 20200630; https://ClinicalTrials.gov/show/NCT02665065
2. Phase 1 – A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma; 20191201; 20200131; https://ClinicalTrials.gov/show/NCT02998047
3. Phase 1Phase 2 – Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients; 20210101; 20230131; https://ClinicalTrials.gov/show/NCT03932318
4. Phase 1Phase 2 – Venetoclax and Lintuzumab-Ac225 in AML Patients; 20201101; 20221130; https://ClinicalTrials.gov/show/NCT03867682

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 08/05/2018 – 08/09/2019, and Why?

Disclaimer

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 09/02/2018 – 09/3062019:

1) VUZI – Vuzix Corporation
a. Buy at < ~ $1.77
b. Sell at >~ $4.96

2) CGIX – Cancer Genetics, Inc.
a. Buy at < ~ $0.09
b. Sell at >~ $0.34
c. Catalysts:
1. – Estrogen, Diet, Genetics and Endometrial Cancer; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT00587886
2. – Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT03648151
3. – Estrogen, Diet, Genetics and Endometrial Cancer; 20191231; 20191231; https://ClinicalTrials.gov/show/NCT00587886
4. – The IMPACT Study – Identification of Men With a Genetic Predisposition to ProstAte Cancer; 20191201; 20211231; https://ClinicalTrials.gov/show/NCT00261456
5. – Genetics of Wilms Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies; 20191201; 20201231; https://ClinicalTrials.gov/show/NCT00503893
6. – Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes; 20190901; 20190930; https://ClinicalTrials.gov/show/NCT02917798
7. – DNA Repair and Genetic Susceptibility to Lung Cancer; 20190901; 20190930; https://ClinicalTrials.gov/show/NCT00611598
8. – Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients.; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT02542670
9. – Exploring the Link Between Cancer Genetics and PPSP; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT04007861
10. – Early Onset and Familial Gastric Cancer Registry; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT00582257
11. – Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers; 20191201; 20191231; https://ClinicalTrials.gov/show/NCT00579163

3) INUV – Inuvo, Inc.
a. Buy at < ~ $0.19
b. Sell at >~ $0.44

4) VJET – voxeljet AG
a. Buy at < ~ $1.52
b. Sell at >~ $2.45

5) KOPN – Kopin Corporation
a. Buy at < ~ $0.83
b. Sell at >~ $1.34

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks < ~ $10 to Buy next week, 09/02/2018 – 09/3062019, and Why?

Disclaimer

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 12/16/2018 – 12/20/2019:

1) MNI – The McClatchy Company – Trading Below Cash
a. Buy at <~ $0.29
b. Sell at >~ $1.95

2) NVFY – Nova LifeStyle, Inc.
a. Buy at <~ $0.39
b. Sell at >~ $1.02

3) DSS – Document Security Systems, Inc.
a. Buy at <~ $0.25
b. Sell at >~ $0.57

4) SYN – Synthetic Biologics, Inc. – Trading Below Cash
a. Buy at <~ $0.36
b. Sell at >~ $0.55
c. Catalysts:
1. Phase 2 – A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis.; 20191117; 20200115; https://ClinicalTrials.gov/show/NCT03682705
2. NA – Evaluation of Tendon-to-Bone Healing Potential in Arthroscopic Rotator Cuff Repair Through Biological Stimulation; 20191231; 20201231; https://ClinicalTrials.gov/show/NCT03060928
3. Phase 3 – A Phase 3 Study to Compare ABT-494 to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs; 20190707; 20210326; https://ClinicalTrials.gov/show/NCT03086343
4. Phase 4 – Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis; 20191001; 20201031; https://ClinicalTrials.gov/show/NCT01881308
5. NA – A Prospective Case Series Evaluating Surgimend Mp® In Patients Undergoing Complex Abdominal Hernia Repair; 20200103; 20210103; https://ClinicalTrials.gov/show/NCT03450473
6. Phase 1Phase 2 – A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.; 20200201; 20200229; https://ClinicalTrials.gov/show/NCT01789099
7. – Prospective Follow-up of Patients With Chronic Inflammatory Rheumatism; 20200101; 20200101; https://ClinicalTrials.gov/show/NCT03076866
8. Phase 2 – Efficacy and Safety of SYN-010 in IBS-C; 20200101; 20200101; https://ClinicalTrials.gov/show/NCT03763175
9. Phase 4 – Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia; 20170901; 20200831; https://ClinicalTrials.gov/show/NCT02242526
10. NA – Influence of Aspirin on Human Gut Microbiota Composition and Metabolome; 20190228; 20191231; https://ClinicalTrials.gov/show/NCT03450317
11. Phase 3 – A Study to Compare ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs; 20170403; 20200806; https://ClinicalTrials.gov/show/NCT02706847
12. Phase 3 – A Study to Compare Upadacitinib (ABT-494) to Placebo in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs; 20170403; 20210916; https://ClinicalTrials.gov/show/NCT02706847
13. – Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway; 20190607; 20200131; https://ClinicalTrials.gov/show/NCT03799705
14. Phase 3 – Pre-pectoral Breast Reconstruction PART 1; 20190701; 20201231; https://ClinicalTrials.gov/show/NCT02830685
15. NA – Mesh Type in Ventral Hernia Repair; 20190331; 20220331; https://ClinicalTrials.gov/show/NCT03091790
16. Phase 3 – Pre-pectoral Breast Reconstruction PART 2; 20190601; 20201231; https://ClinicalTrials.gov/show/NCT02831426
17. Phase 3 – A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs ( SELECT-CHOICE ); 20200229; 20220607; https://ClinicalTrials.gov/show/NCT03086343
18. Phase 1 – CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia; 20210801; 20220801; https://ClinicalTrials.gov/show/NCT03854994
19. Phase 4 – Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders; 20210901; 20221130; https://ClinicalTrials.gov/show/NCT03227419
20. NA – Tissue Reinforcement of Incisional Closure Among High Risk Patients; 20201201; 20221231; https://ClinicalTrials.gov/show/NCT03148496
21. NA – Comparison of Arthroscopic Supraspinatus Tendon Tear Repair in Patients Over 60 Years With and Without Patch Augmentation.; 20210101; 20210101; https://ClinicalTrials.gov/show/NCT03511547
22. – Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings; 20230930; 20230930; https://ClinicalTrials.gov/show/NCT02758769
23. – Corrona Japan Rheumatoid Arthritis (RA) Registry; 21001201; 21001231; https://ClinicalTrials.gov/show/NCT02737449
24. Phase 4 – Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER); 20211231; 20211231; https://ClinicalTrials.gov/show/NCT03886038
25. NA – Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings; 20230930; 20230930; https://ClinicalTrials.gov/show/NCT02758769
26. – Study of the Relation Between Lipid Myocardial Overload Evaluated by Cardiac Magnetic Resonance Imaging (MRI), Alteration of Longitudinal Myocardial Deformations by Echocardiography, and Clinical Achievements (Functional, Biological and Electrical) in Fabry Disease, and Its Outcomes.; 20200418; 20200418; https://ClinicalTrials.gov/show/NCT03123523
27. NA – New Diagnostic Approach for Congenital Toxoplasmosis; 20200501; 20201231; https://ClinicalTrials.gov/show/NCT03385499
28. NA – PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure; 20200301; 20250331; https://ClinicalTrials.gov/show/NCT03445936
29. NA – Study of the Relation Between Lipid Myocardial Overload Evaluated by Cardiac Magnetic Resonance Imaging (MRI), Alteration of Longitudinal Myocardial Deformations by Echocardiography, and Clinical Achievements (Functional, Biological and Electrical) in Fabry Disease, and Its Outcomes.; 20200418; 20200418; https://ClinicalTrials.gov/show/NCT03123523
30. Phase 4 – Rheumatoid Arthritis Memory B Cells and Abatacept (RAMBA); 20200901; 20201230; https://ClinicalTrials.gov/show/NCT03652961
31. – Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients; 20201001; 20201031; https://ClinicalTrials.gov/show/NCT02476084
32. Phase 1Phase 2 – A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer; 20200701; 20200731; https://ClinicalTrials.gov/show/NCT01784913
33. Phase 2 – Oxandrolone Rotator Cuff Trial; 20200701; 20201231; https://ClinicalTrials.gov/show/NCT03091075

5) RIOT – Riot Blockchain, Inc.
a. Buy at <~ $1.28
b. Sell at >~ $1.88

6) DNN – Denison Mines Corp.
a. Buy at <~ $0.38
b. Sell at >~ $0.52

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 12/16/2018 – 12/20/2019, and Why?

Disclaimer

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/06/2020 – 01/10/2020:

1) DSS – Document Security Systems, Inc.
a. Buy at <~ $0.25
b. Sell at >~ $0.57

2) CLIR – ClearSign Technologies Corporation
a. Buy at <~ $0.71
b. Sell at >~ $1.50

3) OXBR – Oxbridge Re Holdings Limited – Trading Below Cash
a. Buy at <~ $0.70
b. Sell at >~ $1.31

4) RIOT – Riot Blockchain, Inc.
a. Buy at <~ $1.11
b. Sell at >~ $1.88

5) DNN – Denison Mines Corp.
a. Buy at <~ $0.38
b. Sell at >~ $0.52

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/06/2020 – 01/10/2020, and Why?

Disclaimer

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/10/2020 – 02/14/2020:

1) WWR – Westwater Resources, Inc.
a. Buy at <~ $1.96
b. Sell at >~ $9.25

2) VUZI – Vuzix Corporation
a. Buy at <~ $1.65
b. Sell at >~ $4.96

3) AVGR – Avinger, Inc. – Trading Below Cash
a. Buy at <~ $0.60
b. Sell at >~ $1.56

4) ARTW – Art’s-Way Manufacturing Co., Inc.
a. Buy at <~ $1.75
b. Sell at >~ $3.24

5) RIOT – Riot Blockchain, Inc.
a. Buy at <~ $1.11
b. Sell at >~ $1.88

6) ACRX – AcelRx Pharmaceuticals, Inc.
a. Buy at <~ $1.64
b. Sell at >~ $2.50

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/10/2020 – 02/14/2020, and Why?

Disclaimer

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 02/22/2020 include:

1. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
2. $AVGR – Avinger, Inc. :
   1. Cash/sh = $0.88
3. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $4.39
4. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $0.76
5. $PHIO – Phio Pharmaceuticals Corp. :
   1. Cash/sh = $13.59
6. $TCON – TRACON Pharmaceuticals, Inc. :
   1. Cash/sh = $6.39
7. $TTPH – Tetraphase Pharmaceuticals, Inc. :
   1. Cash/sh = $4.16

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 02/22/2020 include:

1. $ARCW – ARC Group Worldwide, Inc. :
   1. Book/sh = $0.89
2. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
3. $AVGR – Avinger, Inc. :
   1. Book/sh = $1.11
4. $CHFS – CHF Solutions, Inc. :
   1. Book/sh = $1.64
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $6.63
6. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $0.81
7. $IZEA – IZEA Worldwide, Inc. :
   1. Book/sh = $0.49
8. $KOPN – Kopin Corporation :
   1. Book/sh = $0.44
9. $NNDM – Nano Dimension Ltd. :
   1. Book/sh = $1.44
10. $PHIO – Phio Pharmaceuticals Corp. :
    1. Book/sh = $16.46
11. $ROSGQ – Rosetta Genomics Ltd. :
    1. Book/sh = $0.43
12. $SNCA – Seneca Biopharma, Inc. :
    1. Book/sh = $2.37
13. $SUNW – Sunworks, Inc. :
    1. Book/sh = $1.84
14. $TTPH – Tetraphase Pharmaceuticals, Inc. :
    1. Book/sh = $9.80
15. $VISL – Vislink Technologies, Inc. :
    1. Book/sh = $0.96
16. $VXRT – Vaxart, Inc. :
    1. Book/sh = $1.16
17. $YTEN – Yield10 Bioscience, Inc. :
    1. Book/sh = $8.37

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) and/or Trading Below Book (TBB) here in this Topic as well, ok?

#TradingBelowCash #TBC #TradingBelowBook #TBB #StockPicks #Stock #Market #Trading

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/23/2020 – 02/28/2020:

1) WWR – Westwater Resources, Inc.
a. Buy at <~ $1.96
b. Sell at >~ $9.25

2) ACHV – Achieve Life Sciences, Inc.
a. Buy at <~ $0.46
b. Sell at >~ $1.78
c. Catalysts:
1. Phase 1Phase 2 – Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers; 20200831; 20210228; https://ClinicalTrials.gov/show/NCT03761914
2. – The Pregnancy & Early Life Study; 20230601; 20230630; https://ClinicalTrials.gov/show/NCT03916874

3) ENZ – Enzo Biochem, Inc.
a. Buy at <~ $2.16
b. Sell at >~ $4.45

4) RIOT – Riot Blockchain, Inc.
a. Buy at <~ $1.11
b. Sell at >~ $1.88

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/23/2020 – 02/28/2020, and Why?

Disclaimer

[best digital]

Thank you for sharing information

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 09/08/2020 – 09/11/2020:

1) DYNT – Dynatronics Corporation
a. Buy at <~ $0.63
b. Sell at >~ $1.67

2) PXLW – Pixelworks, Inc.
a. Buy at <~ $2.02
b. Sell at >~ $4.97

3) DDD – 3D Systems Corporation
a. Buy at <~ $5.19
b. Sell at >~ $12.56

4) CHEK – Check-Cap Ltd.
a. Buy at <~ $0.30
b. Sell at >~ $0.68
c. Catalysts:
1. – Development Study of Check-Cap Imaging System in Healthy Volunteers; 20210202; 20210228; https://ClinicalTrials.gov/show/NCT03989180

5) XXII – 22nd Century Group, Inc.
a. Buy at <~ $0.57
b. Sell at >~ $1.01

6) MSN – Emerson Radio Corp. – Trading Below Cash
a. Buy at <~ $0.65
b. Sell at >~ $1.03

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 09/08/2020 – 09/11/2020, and Why?

Disclaimer

[Michael DeVries]

I am Bullish on $TMBR – Timber Pharmaceuticals, Inc. – as a Buy for a Swing Trade with a Price Target of >~ $1.63.

Reasoning:
1) Trading Below Cash: Cash/sh = 0.98 ;

2) High Short Float = 15.84% => Potential Short Squeeze ;

3) Recent Positive News:
3.1) Dec-15-20 08:00AM Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Lead Asset TMB-001 => https://finance.yahoo.com/news/timber-pharmaceuticals-receives-notice-allowance-130000715.html ;

4) Near Term Catalyst(s): Description StartDate EndDate URL :
4.1) Phase 2 – A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis 20210330 20210430 https://ClinicalTrials.gov/show/NCT04154293 ;
4.2) Phase 3 – A Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis (Measure Up 2) 20210120 20230609 https://ClinicalTrials.gov/show/NCT03607422 ;

What do you all think of $TMBR – Timber Pharmaceuticals, Inc. – as a Buy for a Swing Trade right now? and what would be your Price Target for such a Swing Trade on $TMBR?

What other Stocks do You feel would be Good Buys for a Swing Trade right now? and Why?

Please Share and let’s discuss all of this herein for Everyone’s Benefit, ok?

I hope this all helps. Good Luck! and Have a Great Trading Day!

• Michael S. DeVries

 

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/16/2021 – 02/19/2021:

1) GLPG – Galapagos NV
a. Buy at <~ $85.00
b. Sell at >~ $274.03
c. Catalysts:
1. Phase 1 – Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects; 20210201; 20210228; https://ClinicalTrials.gov/show/NCT04736927

2) TTNP – Titan Pharmaceuticals, Inc.
a. Buy at <~ $2.82
b. Sell at >~ $8.84
c. Catalysts:
1. Phase 3 – A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC; 20201104; 20220713; https://ClinicalTrials.gov/show/NCT02489318
2. Early Phase 1 – Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors; 20201201; 20210630; https://ClinicalTrials.gov/show/NCT03454243
3. – The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research; 20501230; 20510130; https://ClinicalTrials.gov/show/NCT03158090

3) CLEU – China Liberal Education Holdings Limited
a. Buy at <~ $3.40
b. Sell at >~ $10.46

4) HYMC – Hycroft Mining Holding Corporation
a. Buy at <~ $6.45
b. Sell at >~ $16.17

5) TRIT – Triterras, Inc.
a. Buy at <~ $6.50
b. Sell at >~ $15.45

6) NRBO – NeuroBo Pharmaceuticals, Inc.
a. Buy at <~ $4.82
b. Sell at >~ $10.98

7) RNA – Avidity Biosciences, Inc.
a. Buy at <~ $21.88
b. Sell at >~ $37.45
c. Catalysts:
1. AOC 1001 for DM1 on track for initiation of Phase 1/2 study in 2H 2021; 20210701; 20211231; https://finance.yahoo.com/news/avidity-biosciences-announces-2021-pipeline-133000760.html

8) RMO – Romeo Power, Inc.
a. Buy at <~ $17.50
b. Sell at >~ $38.90

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/16/2021 – 02/19/2021, and Why?

Disclaimer

[Michael DeVries]

I am Bullish on $ROKU as a Buy for a Long Term Swing Trade with a Long Term Price Target of >~ $486.7.

Reasoning:
1) ER 02/18/2021 $-0.07 (est), +$0.49 (act) ;

2) Positive Recent News:
2.1) Rokus Nielsen Deal Means It Can Make Money Off Traditional TV Viewers. Heres How => https://www.barrons.com/articles/roku-stock-nielsen-deal-traditional-tv-viewers-51614812063?siteid=yhoof2 ; https://finance.yahoo.com/news/roku-redefining-video-monetization-analyst-142710063.html ;
2.2) Roku Is ‘Redefining Video Monetization,’ Analyst Says In Stock Upgrade => https://finance.yahoo.com/news/roku-redefining-video-monetization-analyst-142710063.html ;
2.3) Roku stock rallies after KeyBanc turns bullish, sets $518 price target => https://www.marketwatch.com/story/roku-stock-rallies-after-keybanc-turns-bullish-sets-518-price-target-2021-03-03?siteid=yhoof2 ;
3) Cathie Wood / ARK Buying => https://ark-funds.com/investor-resources

Roku, Inc., together with its subsidiaries, operates a TV streaming platform. The company operates in two segments, Platform and Player. Its platform allows users to discover and access various movies and TV episodes, as well as live sports, music, news, and others. As of December 31, 2019, the company had 36.9 million active accounts. It also provides advertising products, including videos ads, brand sponsorships, and audience development campaigns; and manufactures, sells, and licenses TVs under the Roku TV name, as well as subscription and billing services. In addition, the company offers streaming media players and accessories under the Roku brand name; and sells branded channel buttons on remote controls. It provides its products and services through retailers and distributors, as well as directly to customers through its website in the United States, Canada, the United Kingdom, France, the Republic of Ireland, Mexico, and various Latin American countries. The company was founded in 2002 and is headquartered in San Jose, California.

What do you all think of $ROKU as a Buy for a Swing Trade right now? and what would be your Price Target for such a Swing Trade on $ROKU?

What other Stocks do You feel would be Good Buys for a Swing Trade right now? and Why?

Please Share and let’s discuss all of this herein for Everyone’s Benefit, ok?

I hope this all helps. Good Luck! and Have a Great Trading Day!

Michael S. DeVries

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 04/05/2021 – 04/09/2021:

1) LAIX – LAIX Inc.
a. Buy at <~ $2.08
b. Sell at >~ $11.64

2) CLEU – China Liberal Education Holdings Limited
a. Buy at <~ $3.40
b. Sell at >~ $10.46

3) UAVS – AgEagle Aerial Systems, Inc.
a. Buy at <~ $6.00
b. Sell at >~ $17.67

4) VLDR – Velodyne Lidar, Inc.
a. Buy at <~ $11.00
b. Sell at >~ $32.49

5) MTLS – Materialise NV
a. Buy at <~ $30.00
b. Sell at >~ $87.39

6) MARK – Remark Holdings, Inc.
a. Buy at <~ $2.04
b. Sell at >~ $4.72

7) PLUG – Plug Power Inc.
a. Buy at <~ $30.40
b. Sell at >~ $75.49

8) SNOW – Snowflake Inc.
a. Buy at <~ $208.55
b. Sell at >~ $429.00

9) NXTD – Nxt-ID, Inc.
a. Buy at <~ $1.06
b. Sell at >~ $3.72

10) QUIK – QuickLogic Corporation
a. Buy at <~ $6.50
b. Sell at >~ $12.48

11) LAZR – Luminar Technologies, Inc.
a. Buy at <~ $22.18
b. Sell at >~ $40.15

12) TOMZ – TOMI Environmental Solutions, Inc.
a. Buy at <~ $3.73
b. Sell at >~ $6.49

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/05/2021 – 04/09/2021, and Why?

Disclaimer

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 04/26/2021 – 04/30/2021:

1) MICT – MICT, Inc.
a. Buy at <~ $1.45
b. Sell at >~ $8.44

2) ASXC – Asensus Surgical, Inc.
a. Buy at <~ $1.38
b. Sell at >~ $6.94
c. Catalysts:
1. – The TransEnterix European Patient Registry; 20250101; 20250331; https://ClinicalTrials.gov/show/NCT03385109

3) MTLS – Materialise NV
a. Buy at <~ $28.45
b. Sell at >~ $87.39

4) EMAN – eMagin Corporation
a. Buy at <~ $2.40
b. Sell at >~ $5.24

5) MP – MP Materials Corp.
a. Buy at <~ $26.67
b. Sell at >~ $51.76

6) QUIK – QuickLogic Corporation
a. Buy at <~ $5.62
b. Sell at >~ $12.48

7) PZG – Paramount Gold Nevada Corp.
a. Buy at <~ $1.00
b. Sell at >~ $1.58

8) AAOI – Applied Optoelectronics, Inc.
a. Buy at <~ $7.20
b. Sell at >~ $12.07

9) MAGS – Magal Security Systems Ltd.
a. Buy at <~ $4.01
b. Sell at >~ $7.99

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/26/2021 – 04/30/2021, and Why?

Disclaimer

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 05/03/2021 – 05/07/2021:

1) MICT – MICT, Inc.
a. Buy at <~ $1.45
b. Sell at >~ $8.44

2) ASXC – Asensus Surgical, Inc.
a. Buy at <~ $1.38
b. Sell at >~ $6.94
c. Catalysts:
1. – The TransEnterix European Patient Registry; 20250101; 20250331; https://ClinicalTrials.gov/show/NCT03385109

3) EMAN – eMagin Corporation
a. Buy at <~ $2.40
b. Sell at >~ $5.24

4) AREC – American Resources Corporation
a. Buy at <~ $2.75
b. Sell at >~ $5.67

5) MP – MP Materials Corp.
a. Buy at <~ $26.67
b. Sell at >~ $51.76

6) QUIK – QuickLogic Corporation
a. Buy at <~ $5.62
b. Sell at >~ $12.48

7) PPSI – Pioneer Power Solutions, Inc.
a. Buy at <~ $3.72
b. Sell at >~ $6.50

8) TDOC – Teladoc Health, Inc.
a. Buy at <~ $149.00
b. Sell at >~ $307.99

9) AAOI – Applied Optoelectronics, Inc.
a. Buy at <~ $7.40
b. Sell at >~ $12.07

10) MAGS – Magal Security Systems Ltd.
a. Buy at <~ $4.01
b. Sell at >~ $7.99

11) BA – The Boeing Company
a. Buy at <~ $230.22
b. Sell at >~ $446.00

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 05/03/2021 – 05/07/2021, and Why?

Disclaimer

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 05/10/2021 – 05/14/2021:

1) TEVA – Teva Pharmaceutical Industries Limited
a. Buy at <~ $10.01
b. Sell at >~ $11.98

2) MAGS – Magal Security Systems Ltd.
a. Buy at <~ $4.01
b. Sell at >~ $7.99

3) PPSI – Pioneer Power Solutions, Inc.
a. Buy at <~ $3.58
b. Sell at >~ $6.49

4) KOPN – Kopin Corporation
a. Buy at <~ $6.94
b. Sell at >~ $13.61

5) QUIK – QuickLogic Corporation
a. Buy at <~ $5.62
b. Sell at >~ $12.48

6) MP – MP Materials Corp.
a. Buy at <~ $26.67
b. Sell at >~ $51.76

7) EBS – Emergent BioSolutions Inc.
a. Buy at <~ $59.00
b. Sell at >~ $127.69

8) JUPW – Jupiter Wellness, Inc.
a. Buy at <~ $4.00
b. Sell at >~ $8.87
c. Catalysts:
1. – Beat COVID-19 – Observational Trial; 20201201; 20210731; https://ClinicalTrials.gov/show/NCT04337762
2. Phase 3 – Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkins Lymphoma; 20130901; 20230930; https://ClinicalTrials.gov/show/NCT00075946
3. – Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode; 20220101; 20240101; https://ClinicalTrials.gov/show/NCT04136002
4. Phase 1 – JOTROL PK, Safety, and Food Effect Assessment; 20210228; 20210531; https://ClinicalTrials.gov/show/NCT04668274

9) MOSY – MoSys, Inc.
a. Buy at <~ $3.20
b. Sell at >~ $7.11

10) EMAN – eMagin Corporation
a. Buy at <~ $2.30
b. Sell at >~ $5.24

11) MSN – Emerson Radio Corp. – Trading Below Cash
a. Buy at <~ $1.08
b. Sell at >~ $2.59

12) SSYS – Stratasys Ltd.
a. Buy at <~ $20.00
b. Sell at >~ $56.94

13) ASXC – Asensus Surgical, Inc.
a. Buy at <~ $1.38
b. Sell at >~ $6.94
c. Catalysts:
1. – The TransEnterix European Patient Registry; 20250101; 20250331; https://ClinicalTrials.gov/show/NCT03385109

14) MICT – MICT, Inc.
a. Buy at <~ $1.45
b. Sell at >~ $8.44

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 05/10/2021 – 05/14/2021, and Why?

Disclaimer

[Author]

Posts